n-methylaspartate has been researched along with Pancreatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burel-Vandenbos, F; Coulomb-l'Hermine, A; Cros, J; Dadone-Montaudié, B; Kubiniek, V; Paoli, C; Pedeutour, F; Pondrom, M | 1 |
1 other study(ies) available for n-methylaspartate and Pancreatic Neoplasms
| Article | Year |
|---|---|
AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma.
Topics: Adult; Carcinoma, Acinar Cell; Child; Humans; Mitogen-Activated Protein Kinase Kinases; Mutation; N-Methylaspartate; Pancreatic Neoplasms; Proto-Oncogene Proteins B-raf | 2022 |